Leading a $60M launch round, RA Capital backs another 'toad venom' startup
Summary
While the first mRNA shot became available 326 days after the SARS-CoV-2 virus was sequenced, the journey of Corbevax which has so far gone into the arms of 75 million kids in India and recently won approval for adults spanned about 600 days.But Peter Hotez, one of its co-inventors, believes it couldve played out differently if his team had received more funding and there was a smoother regulatory path.That could have been probably cut in half had we had the support to move faster, said Hotez, the co-director of the Texas Childrens Hospital Center for Vaccine Development.There was good reason to go faster. The mad scramble for life-saving shots exposed the stark disparities between the vaccine haves and have-nots. Vexing scientific, regulatory and manufacturing challenges must be solved ahead of the next pandemic, public health experts and advocacy group representatives said in interviews.The Coalition for Epidemic Preparedness Innovations, or CEPI, which launched in 2017 in the wake of the Ebola outbreak in West Africa, has proposed what it calls a moonshot goal of spurring a vaccine against a new pandemic-causing pathogen in 100 days. The initiative is known as the 100 Days Mission.Melanie Saville, CEPIs executive director of vaccine R&D, reckons the group wouldve been laughed out of the room if they had told people before the Covid-19 pandemic that a vaccine would arrive within 326 days but already theres a path to going faster.If you actually put everybodys innovation together from Covid-19, we already probably could shave off two months by looking meticulously at every step of the process, she said, citing a CEPI analysis based on interviews with companies, international organizations, regulatory agencies, academia and the media.To get to 100 days, though, much more needs to be done. The key is to do as much of it upfront as possible, she added, during so-called peacetime, much like decades-long RNA research ushered in the first Covid-19 vaccines.